Astera Labs: Superb Q1, But Faster Times Ahead
Astera Labs delivered a Q1 quadruple beat, raising Q2 guidance at least 16% above consensus, and rem…

Intelligence analysis not yet available for this stock. Full AI-powered analysis may be available on the intelligence page.
Trend
+10.6% vs SMA 50 · +60.8% vs SMA 200
Momentum
Accumulation pattern present — more buying days than selling over the past 20 sessions. Volume conditions support gradual price improvement.
Based on volume distribution analysis. Direct short interest data (short float %, days to cover) is not available in current data sources.
Analyst consensus estimates · Actuals replace estimates as reported
| Year | Revenue Est. | Rev Gth | EPS Est. | EPS Gth | Range | Analysts |
|---|---|---|---|---|---|---|
FY2025 | $2.3B $2.1B–$2.5B | — | $0.51 | — | ±1% | High5 |
FY2026(current) | $2.7B $2.5B–$3.0B | ▲ +20.2% | $0.75 | ▲ +46.8% | ±3% | Moderate3 |
FY2027 | $3.0B $2.8B–$3.4B | ▲ +11.7% | $0.98 | ▲ +30.7% | ±3% | Moderate4 |
Dividend per payment — last 8 periods
Astera Labs delivered a Q1 quadruple beat, raising Q2 guidance at least 16% above consensus, and rem…

No description available.
| Symbol | Price | Day % | Mkt Cap↓ | P/E | Rev Grw | Margin | ELO |
|---|---|---|---|---|---|---|---|
AHR◀ | $48.09 | -0.90% | $9.0B | 118.2 | +914.9% | 308.9% | 1500 |
| $214.30 | -1.31% | $151.3B | 106.5 | +3582.4% | 878.3% | 1511 | |
| $140.27 | +1.09% | $130.8B | 35.1 | +717.6% | 3880.1% | 1505 | |
| $1078.46 | -0.44% | $106.4B | 74.6 | +585.3% | 1457.9% | 1524 | |
| $178.12 | -1.53% | $83.0B | 28.9 | +511.4% | 2376.5% | 1491 | |
| $196.69 | -0.92% | $68.6B | 49.2 | +1004.0% | 2140.8% | 1518 | |
| $202.31 | +0.40% | $65.7B | 14.3 | +671.9% | 7251.1% | 1507 | |
| Sector avg | — | -0.51% | — | 61.0 | +1141.1% | 2613.4% | 1508 |